Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly R Reveles

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
International Journal of Antimicrobial Agents|August 29, 2022
A Comparison of Outcomes With and Without Infectious Diseases Consultation for Enterococcal Bacteraemia in a Multicenter Healthcare SystemEmily A Shephard, Kristin Mondy, Kelly R Reveles, et al.
European Urology Open Science|November 29, 2023
Comparative Effectiveness Randomized Clinical Trial Using Next-generation Microbial Sequencing to Direct Prophylactic Antibiotic Choice Before Urologic Stone Lithotripsy Using an Interprofessional ModelMichael A Liss, Kelly R Reveles, Craig D Tipton, et al.
Plos One|August 3, 2021
Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016Eric H Young, Samantha Pan, Alex G Yap, et al.
Plos One|May 13, 2021
Gut microbiome differences among Mexican Americans with and without type 2 diabetes mellitusAmanda K Kitten, Laurajo Ryan, Grace C Lee, et al.
Oral Diseases|September 22, 2019
Can oral health and oral-derived biospecimens predict progression of dementia?Miranda E Orr, Kelly R Reveles, Chih-Ko Yeh, et al.
Gut|October 11, 2017
Proton pump inhibitor use associated with changes in gut microbiota compositionKelly R Reveles, Caitlin N Ryan, Luisa Chan, et al.
Pharmacotherapy|October 19, 2017
Fidaxomicin versus Vancomycin as a First-Line Treatment for Clostridium difficile-Associated Diarrhea in Specific Patient Populations: A Pharmacoeconomic EvaluationKelly R Reveles, Jennifer L Backo, Frank A Corvino, et al.
Journal of the American Pharmacists Association : Japha|August 3, 2025
Assessing the accessibility and accuracy of pharmacist counseling for continuous glucose monitoring: A secret shopper study of community pharmaciesMorgan P Stewart, Lindsey J Loera, Bruno Onwukwe, et al.
Journal of the American Pharmacists Association : Japha|July 27, 2014
How gaps in regulation of compounding pharmacy set the stage for a multistate fungal meningitis outbreakBesu F Teshome, Kelly R Reveles, Grace C Lee, et al.
Microorganisms|February 25, 2023
Controversies in the Prevention and Treatment of <i>Clostridioides difficile</i> Infection in Adults: A Narrative ReviewTaryn B Bainum, Kelly R Reveles, Ronald G Hall, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
International Journal of Antimicrobial Agents|August 29, 2022
A Comparison of Outcomes With and Without Infectious Diseases Consultation for Enterococcal Bacteraemia in a Multicenter Healthcare SystemEmily A Shephard, Kristin Mondy, Kelly R Reveles, et al.
European Urology Open Science|November 29, 2023
Comparative Effectiveness Randomized Clinical Trial Using Next-generation Microbial Sequencing to Direct Prophylactic Antibiotic Choice Before Urologic Stone Lithotripsy Using an Interprofessional ModelMichael A Liss, Kelly R Reveles, Craig D Tipton, et al.
Plos One|August 3, 2021
Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016Eric H Young, Samantha Pan, Alex G Yap, et al.
Plos One|May 13, 2021
Gut microbiome differences among Mexican Americans with and without type 2 diabetes mellitusAmanda K Kitten, Laurajo Ryan, Grace C Lee, et al.
Oral Diseases|September 22, 2019
Can oral health and oral-derived biospecimens predict progression of dementia?Miranda E Orr, Kelly R Reveles, Chih-Ko Yeh, et al.
Gut|October 11, 2017
Proton pump inhibitor use associated with changes in gut microbiota compositionKelly R Reveles, Caitlin N Ryan, Luisa Chan, et al.
Pharmacotherapy|October 19, 2017
Fidaxomicin versus Vancomycin as a First-Line Treatment for Clostridium difficile-Associated Diarrhea in Specific Patient Populations: A Pharmacoeconomic EvaluationKelly R Reveles, Jennifer L Backo, Frank A Corvino, et al.
Journal of the American Pharmacists Association : Japha|August 3, 2025
Assessing the accessibility and accuracy of pharmacist counseling for continuous glucose monitoring: A secret shopper study of community pharmaciesMorgan P Stewart, Lindsey J Loera, Bruno Onwukwe, et al.
Journal of the American Pharmacists Association : Japha|July 27, 2014
How gaps in regulation of compounding pharmacy set the stage for a multistate fungal meningitis outbreakBesu F Teshome, Kelly R Reveles, Grace C Lee, et al.
Microorganisms|February 25, 2023
Controversies in the Prevention and Treatment of <i>Clostridioides difficile</i> Infection in Adults: A Narrative ReviewTaryn B Bainum, Kelly R Reveles, Ronald G Hall, et al.
Pageof 9